These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23601054)

  • 1. Optimizing the duration of assessment of stage-1 sacral neuromodulation in nonobstructive chronic urinary retention.
    Elneil S; Abtahi B; Helal M; Digesu A; Gonzales G
    Neuromodulation; 2014 Jan; 17(1):66-70; discussion 70-1. PubMed ID: 23601054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sacral neuromodulation in urology. The emperor's new clothes or effective high-tech medicine?].
    Hoda MR; Fornara P
    Urologe A; 2010 Oct; 49(10):1254-9. PubMed ID: 20859609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of urodynamic tools to guide patient selection in sacral neuromodulation.
    Drossaerts J; Rademakers K; van Koeveringe G; Van Kerrebroeck P
    World J Urol; 2015 Nov; 33(11):1889-95. PubMed ID: 25680936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Onset of Action of Sacral Neuromodulation in Lower Urinary Tract Dysfunction-What is the Optimal Duration of Test Stimulation?
    Jairam R; Drossaerts J; Marcelissen T; van Koeveringe G; van Kerrebroeck P
    J Urol; 2018 Jun; 199(6):1584-1590. PubMed ID: 29291416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving clinical outcomes for women with overactive bladder or urinary retention symptoms: a comparison of motor response voltages (1-9 V) during Stage 1 sacral neuromodulation.
    Marinkovic SP; Ford JC
    BJU Int; 2018 Sep; 122(3):472-479. PubMed ID: 29637712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sacral neuromodulation outcomes in male patients with chronic urinary retention.
    Saber-Khalaf M; Abtahi B; Gonzales G; Helal M; Elneil S
    Neuromodulation; 2015 Jun; 18(4):329-34; discussion 334. PubMed ID: 25655708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Value of Ambulatory Urodynamics in the Evaluation of Treatment Effect of Sacral Neuromodulation.
    Drossaerts J; Rademakers KLJ; Rahnama'i SM; Marcelissen T; Van Kerrebroeck P; van Koeveringe G
    Urol Int; 2019; 102(3):299-305. PubMed ID: 30612126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sacral neuromodulation in under- and overactive detrusor-quo vadis? : Principles and developments].
    Girtner F; Burger M; Mayr R
    Urologe A; 2019 Jun; 58(6):634-639. PubMed ID: 31139864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PNE versus 1st stage tined lead procedure: a direct comparison to select the most sensitive test method to identify patients suitable for sacral neuromodulation therapy.
    Leong RK; De Wachter SG; Nieman FH; de Bie RA; van Kerrebroeck PE
    Neurourol Urodyn; 2011 Sep; 30(7):1249-52. PubMed ID: 21404317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of Duration of Complaints on Successful Outcome of Sacral Neuromodulation.
    Jairam R; Drossaerts J; van Koeveringe G; van Kerrebroeck P
    Urol Int; 2017; 99(1):51-55. PubMed ID: 28478446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early sacral neuromodulation ameliorates urinary bladder function and structure in complete spinal cord injury minipigs.
    Keller EE; Patras I; Hutu I; Roider K; Sievert KD; Aigner L; Janetschek G; Lusuardi L; Zimmermann R; Bauer S
    Neurourol Urodyn; 2020 Feb; 39(2):586-593. PubMed ID: 31868966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of sacral neuromodulation in modern urogynaecology practice: a review of recent literature.
    Tahseen S
    Int Urogynecol J; 2018 Aug; 29(8):1081-1091. PubMed ID: 29302716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sacral neuromodulation for neurogenic non-obstructive urinary retention in incomplete spinal cord patients: a ten-year follow-up single-centre experience.
    Lombardi G; Musco S; Celso M; Del Corso F; Del Popolo G
    Spinal Cord; 2014 Mar; 52(3):241-5. PubMed ID: 24394604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of sacral neuromodulation on pudendal nerve function and female sexual function.
    Parnell BA; Howard JF; Geller EJ
    Neurourol Urodyn; 2015 Jun; 34(5):456-60. PubMed ID: 24615871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Supervised 3 Weeks Test Phase in Sacral Neuromodulation with a 1-Year Followup.
    Tilborghs S; Van de Borne S; Vaganée D; De Win G; De Wachter S
    J Urol; 2021 Jan; 205(1):206-212. PubMed ID: 32716692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urodynamic findings during the filling phase in neurogenic bladder patients with or without vesicoureteral reflux who have undergone sacral neuromodulation.
    Chen G; Liao L; Wang Y; Ying X
    Neurourol Urodyn; 2020 Jun; 39(5):1410-1416. PubMed ID: 32282088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal Lead Positioning in Sacral Neuromodulation: Which Factors Are Related to Treatment Outcome?
    Jairam R; Marcelissen T; van Koeveringe G; van Kerrebroeck P
    Neuromodulation; 2017 Dec; 20(8):830-835. PubMed ID: 28877395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sacral Nerve Stimulation for Pediatric Lower Urinary Tract Dysfunction: Development of a Standardized Pathway with Objective Urodynamic Outcomes.
    Schober MS; Sulkowski JP; Lu PL; Minneci PC; Deans KJ; Teich S; Alpert SA
    J Urol; 2015 Dec; 194(6):1721-6. PubMed ID: 26141849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sacral neuromodulation treatment for urinary voiding dysfunctions: results of treatment with the largest single-center series in a tertiary referral center in Turkey.
    Kütükoğlu MU; Altuntaş T; Şahin B; Onur AR
    Turk J Med Sci; 2023 Feb; 53(1):206-210. PubMed ID: 36945940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective, multicenter study of a novel, miniaturized rechargeable sacral neuromodulation system: 12-month results from the RELAX-OAB study.
    Blok B; Van Kerrebroeck P; de Wachter S; Ruffion A; Van der Aa F; Jairam R; Perrouin-Verbe MA; Elneil S
    Neurourol Urodyn; 2019 Feb; 38(2):689-695. PubMed ID: 30592526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.